Among these mutations, APP, PSEN1, and PSEN2 mutations represent only a minority of all patient's early-onset AD (EOAD) cases with a familial inheritance, suggesting that APOE (apolipoprotein E) on chromosome 19, may play an important role in disease onset in sporadic cases of EOAD (9, 10). This evidence concerns the gene PSEN1 and Alzheimer disease.